Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06311058 · ClinicalTrials.gov registry record · NA
Protein Supplementation After ACL Surgery
A NA study of ACL Reconstruction, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT06311058: Recruiting NA study of ACL Reconstruction, sponsored by The Methodist Hospital Research Institute.
NCT06311058 is a NA study of ACL Reconstruction that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 102 participants, roughly in line with the 108-participant average among 4 other ACL Reconstruction trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06311058, a NA study of ACL Reconstruction, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the longitudinal post-operative care effects of protein supplementation on muscle atrophy in the post-operative period following ACL reconstruction. The main outcome will be muscle size/mass as measured using dual energy x-ray absorptiometry (DEXA) scanning. The primary objective is to assess for any beneficial impact of protein supplementation, with implications of standardizing a recommended protocol for protein supplementation after ACL reconstruction. Secondary outcomes will be to evaluate the survey data from the KOOS JR and Tampa Scale surveys, as well as functional measures recorded during physical therapy.
Primary Outcome
Lean mass in the effected limb
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey protein isolate
- DIETARY_SUPPLEMENT Protein + BAA
Study Locations (1)
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What NCT06311058 shows while recruiting
NCT06311058 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 108-participant average among 4 other ACL Reconstruction trials with a reported enrollment target.
The record links to 1 condition, with ACL Reconstruction appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06311058 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06311058 about?
NCT06311058 is a clinical study titled "Protein Supplementation After ACL Surgery". The purpose of the study is to assess the longitudinal post-operative care effects of protein supplementation on muscle atrophy in the post-operative period following ACL reconstruction. The main outcome will be muscle size/mass as measured using dual energy x-ray absorptiometry (DEXA) scanning. The...
What is the current status of trial NCT06311058?
This trial is currently recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2024-02-16. Estimated completion is 2027-12-01.
What conditions does trial NCT06311058 study?
This clinical trial studies the following conditions: ACL Reconstruction.
What interventions are being tested in trial NCT06311058?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey protein isolate (DIETARY_SUPPLEMENT), Protein + BAA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06311058?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06311058 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ACL Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery?
RECRUITING · NA
-
A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products
RECRUITING · NA
-
Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft
RECRUITING · NA
-
When do School-aged Patients Return to School After ACL Surgery?
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI